HI
JAZZ icon

Horizon Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Horizon Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$896K Sell
4,740
-6,091
-56% -$1.06M 0.01% 688
2025
Q4 		$1.84M Buy
+10,831
New +$1.66M 0.02% 489
2025
Q3 		– Sell
-83,654
Closed -$8.88M – 1242
2025
Q2 		$8.88M Buy
83,654
+83,638
+522,738% +$9.09M 0.14% 113
2025
Q1 		$1.99K Sell
16
-68
-81% -$8.87K ﹤0.01% 721
2024
Q4 		$10.3K Buy
+84
New +$9.9K ﹤0.01% 676

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Horizon Investments's JAZZ Position: Q1 2026 in Review

Horizon Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 56% in Q1 2026, selling an estimated $1.06M and leaving 4,740 shares worth $896K. The position accounts for 0.01% of the portfolio, ranked #688.

Horizon Investments first reported a position in JAZZ in Q4 2024 and has held it in 5 quarters since. The position peaked at $8.88M in Q2 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Horizon Investments held 4,740 shares of Jazz Pharmaceuticals worth $896K as of Q1 2026.
  • Horizon Investments sold 6,091 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.06M.
  • Jazz Pharmaceuticals made up 0.01% of Horizon Investments's portfolio in Q1 2026, its #688 holding.
  • Horizon Investments first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Horizon Investments's Jazz Pharmaceuticals position peaked at $8.88M in Q2 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.